The study's findings underscore the importance of considering the interplay between air pollution and climate change when evaluating health outcomes. The positive association between ozone concentration and temperature highlights the need to account for these factors when predicting mortality risks. The use of FDA-based models offers a promising approach for capturing the intricate patterns and relationships that elude classical models, providing valuable insights for public health research efforts.